摘要
在科技伦理治理战略指导下,我国伦理审查制度化建设快速推进。伦理审查制度化建设有利于推动伦理审查的规范化发展,但也存在潜在的伦理风险。引入伦理效应视角,以《涉及人的生命科学和医学研究伦理审查办法》为例,在分析政策新要求及其可能的积极影响的基础上,探讨政策落地存在的责任主体界定不明、依从性管理不足等主要挑战,通过对伦理审查制度化建设本身的反思,呼吁加强对政策法规落地实施和实际效果的关注,同时还应在制度化建设之外,强化利益相关方的主体责任和能动性。
In the context of ethical governance strategy of science and technology,the institutionalization of ethical review in China has rapidly developed recently.The institutionalization of ethical review contributed a lot to the standardization of ethical review,however,there are also potential ethical risks.In this paper,from the perspective of ethical effect,the author took the Measures for the Ethical Review of Life Science and Medical Research Involving Human Participant as an example,discussed main challenges of policy implementation,such as unclear definition of responsible entities and insufficient compliance management.Furthermore,reflections on the institutionalization of ethical review policy itself were explored.The author called for more attention to the implementation and effectiveness of policies and regulations.Moreover,beyond institutionalization,it is crucial to strengthen the responsibility and agency of all stakeholders involved.
作者
张海洪
ZHANG Haihong(The Research Department,Peking University Health Science Center,Beijing 100191,China)
出处
《医学与哲学》
北大核心
2024年第21期1-5,共5页
Medicine and Philosophy
关键词
伦理效应
伦理审查制度化
利益相关方
责任
ethical effect
institutionalization of ethical review
stakeholders
responsibility